Eicosapentaenoic acid for prevention of major coronary events

Affiliations

¹ Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. Electronic address: claudio.galli@unimi.it.
² Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.

Free article

Comment

Claudio Galli et al. Lancet. 2007.

Free article

. 2007 Jul 21;370(9583):215.

doi: 10.1016/S0140-6736(07)61113-1.

¹ Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. Electronic address: claudio.galli@unimi.it.
² Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.

No abstract available

Comment on

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators. Yokoyama M, et al. Lancet. 2007 Mar 31;369(9567):1090-8. doi: 10.1016/S0140-6736(07)60527-3. Lancet. 2007. PMID: 17398308 Clinical Trial.